Carnagarin Revathy, Leigh James, Tan Isabella, Gnanenthiran Sonali, Yang Jun, Beaney Thomas, Clarke Jonathan, Poulter Neil R, Brockman Derrin, Schlaich Markus P
Dobney Hypertension Centre, Medical School-Royal Perth Hospital Unit/Royal Perth Hospital Research Foundation, University of Western Australia, Level 3, MRF Building, Rear 50 Murray St, Perth, WA 6000, Australia.
Geraldton Regional Hospital, Western Australian Country Health Service Midwest, Geraldton, Australia.
Eur Heart J Suppl. 2024 Jul 24;26(Suppl 3):iii14-iii16. doi: 10.1093/eurheartjsupp/suae042. eCollection 2024 Jun.
May Measurement Month (MMM) is a global and national blood pressure (BP) screening campaign initiated by the International Society of Hypertension to improve awareness of BP worldwide. This study reports on the findings of the MMM21 campaign in Australia. Adult participants (≥18 years) were screened through opportunistic sampling across Australia between 1 May and 30 November 2021. Trained volunteers recorded standardized BP measurements from community volunteer participants along with demographic data, lifestyle factors, comorbidities, and history of COVID-19 infection and vaccination. Hypertension was defined as systolic BP ≥ 140 mmHg and/or diastolic BP ≥ 90 mmHg and/or taking antihypertensive medication. Data were collated and analysed centrally using the current MMM protocol and presented after the imputation of missing BP readings. A total of 1307 participants were screened in 2021, comprising 652 (49.9%) females and 654 (50.0%) males with a mean age of 48 years (SD 20.1). Of all 1307 participants, 524 (40.1%) had hypertension. Of participants with hypertension, 65.4% were aware and 59.3% were on antihypertensive medication. Of 311 participants on antihypertensive medication, 54.7% had controlled BP. Of all 524 participants with hypertension, 32.5% had controlled BP. The current 2021 data may indicate some progress in creating BP awareness; however, consecutive Australian data obtained since 2017 demonstrated stagnating treatment, and control rates compared with global rates and those in other high-income countries. Concerted efforts from all stakeholders will be required to further improve BP awareness, treatment, and control rates in Australia.
五月测量月（MMM）是由国际高血压学会发起的一项全球和全国性血压筛查活动，旨在提高全球对血压的认识。本研究报告了澳大利亚MMM21活动的结果。2021年5月1日至11月30日期间，成年参与者（≥18岁）通过澳大利亚各地的机会性抽样进行筛查。经过培训的志愿者记录了社区志愿者参与者的标准化血压测量值以及人口统计学数据、生活方式因素、合并症、COVID-19感染和疫苗接种史。高血压的定义为收缩压≥140 mmHg和/或舒张压≥90 mmHg和/或正在服用抗高血压药物。数据使用当前的MMM方案进行集中整理和分析，并在推算缺失的血压读数后呈现。2021年共筛查了1307名参与者，其中女性652名（49.9%），男性654名（50.0%），平均年龄48岁（标准差20.1）。在所有1307名参与者中，524名（40.1%）患有高血压。在患有高血压的参与者中，65.4%知晓病情，59.3%正在服用抗高血压药物。在311名服用抗高血压药物的参与者中，54.7%的血压得到控制。在所有524名患有高血压的参与者中，32.5%的血压得到控制。2021年的当前数据可能表明在提高血压意识方面取得了一些进展；然而，自2017年以来获得的连续澳大利亚数据显示，与全球和其他高收入国家的比率相比，治疗率和控制率停滞不前。需要所有利益相关者共同努力，以进一步提高澳大利亚的血压意识、治疗率和控制率。
